Porphyrin with amino acid moieties: a tumor photosensitizer. 2008

H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
Beijing Institute of Pharmaceutical Chemistry, Beijing 102205, People's Republic of China. h.m.wang401@gmail.com

A porphyrin with amino acid moieties was synthesized in this work, which may be a latent photosensitizer for photodynamic therapy (PDT). Adler's strategy was used to synthesize meso-tetra (4-nitrophenyl) porphyrin (TNPP) through cyclolization of 4-nitrobenzaldhyde and pyrrole in refluxed nitrobenzene. Reduction of TNPP yielded meso-tetra(4-aminophenyl) porphyrin (TAPP). The synthesis was improved by employing lactic acid as a catalyst. Based on TAPP, porphyrin with valine (TAPP-4Val) was obtained. The application of the resultant TAPP-4Val as tumor photosensitizer on human breast tumor cells for photodynamic therapy (PDT) was preliminarily explored. Dark-toxicity evaluations showed that, under a concentration at up to 6 x 10(-6) M, the survival of MCF-7 cells was larger than 90%, which means TAPP-4Val is almost of non-cytotoxicity. However, TAPP-4Val showed remarkable phototoxicity after visible light irradiation. Effects of irradiation time on the survival of cells under typical concentrations of TAPP-4Val were also studied. The new porphyrin with amino acid moieties, TAPP-4Val, is of high phototoxicity but minimal or no dark-toxicity, which can be used as an effective photosensitizer for PDT.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
June 2020, The Journal of organic chemistry,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
April 1994, Archiv der Pharmazie,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
December 1995, Proceedings of the National Academy of Sciences of the United States of America,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
March 2020, Bioconjugate chemistry,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
January 2016, Oncology letters,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
May 2013, ACS applied materials & interfaces,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
December 2018, Journal of enzyme inhibition and medicinal chemistry,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
January 2019, Frontiers in chemistry,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
August 2018, Organic & biomolecular chemistry,
H M Wang, and J Q Jiang, and J H Xiao, and R L Gao, and F Y Lin, and X Y Liu
January 2014, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!